These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 19032668)

  • 21. Regulation of hMSH2 and hMLH1 expression in the human colon cancer cell line SW1116 by DNA methyltransferase 1.
    Fang JY; Lu R; Mikovits JA; Cheng ZH; Zhu HY; Chen YX
    Cancer Lett; 2006 Feb; 233(1):124-30. PubMed ID: 16473673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutational analysis of promoters of mismatch repair genes hMSH2 and hMLH1 in hereditary nonpolyposis colorectal cancer and early onset colorectal cancer patients: identification of three novel germ-line mutations in promoter of the hMSH2 gene.
    Shin KH; Shin JH; Kim JH; Park JG
    Cancer Res; 2002 Jan; 62(1):38-42. PubMed ID: 11782355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promoter methylation and immunohistochemical expression of hMLH1 and hMSH2 in sporadic colorectal cancer: a study from India.
    Malhotra P; Anwar M; Kochhar R; Ahmad S; Vaiphei K; Mahmood S
    Tumour Biol; 2014 Apr; 35(4):3679-87. PubMed ID: 24317816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promoter hypermethylation of mismatch repair genes, hMLH1 and hMSH2 in oral squamous cell carcinoma.
    Czerninski R; Krichevsky S; Ashhab Y; Gazit D; Patel V; Ben-Yehuda D
    Oral Dis; 2009 Apr; 15(3):206-13. PubMed ID: 19207881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defective mismatch repair and the development of recurrent endometrial carcinoma.
    Pijnenborg JM; Dam-de Veen GC; de Haan J; van Engeland M; Groothuis PG
    Gynecol Oncol; 2004 Aug; 94(2):550-9. PubMed ID: 15297202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of hMSH2 and hMSH6 expression is frequent in sporadic endometrial carcinomas with microsatellite instability: a population-based study.
    Stefansson I; Akslen LA; MacDonald N; Ryan A; Das S; Jacobs IJ; Salvesen HB
    Clin Cancer Res; 2002 Jan; 8(1):138-43. PubMed ID: 11801550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypermethylation analysis of mismatch repair genes (hmlh1 and hmsh2) in locally advanced breast cancers in Indian women.
    Naqvi RA; Hussain A; Deo SS; Kukreti H; Chauhan M; Sarin R; Saxena A; Asim M; Shukla NK; Husain SA; Pasha ST; Basir SF
    Hum Pathol; 2008 May; 39(5):672-80. PubMed ID: 18329696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Reversal effect of 5-Aza-dc on cisplatin-resistance in human NSCLC cells in vitro].
    Wu F; Hu CH
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):349-53. PubMed ID: 21875463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylation of the hMLH1 promoter and its association with microsatellite instability in acute myeloid leukemia.
    Seedhouse CH; Das-Gupta EP; Russell NH
    Leukemia; 2003 Jan; 17(1):83-8. PubMed ID: 12529664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence.
    Lee KH; Lee JS; Nam JH; Choi C; Lee MC; Park CS; Juhng SW; Lee JH
    Langenbecks Arch Surg; 2011 Oct; 396(7):1017-26. PubMed ID: 21706233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microsatellite mutations of transforming growth factor-beta receptor type II and caspase-5 occur in human precursor T-cell lymphoblastic lymphomas/leukemias in vivo but are not associated with hMSH2 or hMLH1 promoter methylation.
    Scott S; Kimura T; Ichinohasama R; Bergen S; Magliocco A; Reimer C; Kerviche A; Sheridan D; DeCoteau JF
    Leuk Res; 2003 Jan; 27(1):23-34. PubMed ID: 12479849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypermethylation of the hMLH1 gene promoter in solitary and multiple gastric cancers with microsatellite instability.
    Sakata K; Tamura G; Endoh Y; Ohmura K; Ogata S; Motoyama T
    Br J Cancer; 2002 Feb; 86(4):564-7. PubMed ID: 11870538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microsatellite instability and protein expression of the DNA mismatch repair gene, hMLH1, of lung cancer in chromate-exposed workers.
    Takahashi Y; Kondo K; Hirose T; Nakagawa H; Tsuyuguchi M; Hashimoto M; Sano T; Ochiai A; Monden Y
    Mol Carcinog; 2005 Mar; 42(3):150-8. PubMed ID: 15605365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequent hypermethylation of the hMLH1 gene promoter in differentiated-type tumors of the stomach with the gastric foveolar phenotype.
    Endoh Y; Tamura G; Ajioka Y; Watanabe H; Motoyama T
    Am J Pathol; 2000 Sep; 157(3):717-22. PubMed ID: 10980110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA mismatch repair genes in renal cell carcinoma.
    Deguchi M; Shiina H; Igawa M; Kaneuchi M; Nakajima K; Dahiya R
    J Urol; 2003 Jun; 169(6):2365-71. PubMed ID: 12771799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roles of mismatch repair proteins hMSH2 and hMLH1 in the development of sporadic breast cancer.
    Murata H; Khattar NH; Gu L; Li GM
    Cancer Lett; 2005 Jun; 223(1):143-50. PubMed ID: 15890247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promoter methylation and expression of DNA repair genes hMLH1 and MGMT in acute myeloid leukemia.
    Lenz G; Hutter G; Hiddemann W; Dreyling M
    Ann Hematol; 2004 Oct; 83(10):628-33. PubMed ID: 15309527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability.
    Cunningham JM; Christensen ER; Tester DJ; Kim CY; Roche PC; Burgart LJ; Thibodeau SN
    Cancer Res; 1998 Aug; 58(15):3455-60. PubMed ID: 9699680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. hMLH1 and hMSH2 expression in human hepatocellular carcinoma.
    Wang L; Bani-Hani A; Montoya DP; Roche PC; Thibodeau SN; Burgart LJ; Roberts LR
    Int J Oncol; 2001 Sep; 19(3):567-70. PubMed ID: 11494037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer.
    Strathdee G; MacKean MJ; Illand M; Brown R
    Oncogene; 1999 Apr; 18(14):2335-41. PubMed ID: 10327053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.